Navaneel Kar Appointed as Director General of IPM India

Business by 2FIRSTS.ai

Jan.12.2024

Navaneel Kar Appointed as Director General of IPM India

Philip Morris International (PMI) has appointed Navaneel Kar as the Managing Director of its Indian subsidiary IPM India.

According to international media reports, Philip Morris International has appointed Navaneel Kar as the Managing Director of its Indian subsidiary, IPM India.

Prior to this, Karl served as the Sales President at Tata Consumer Products. He will report directly to Ankur Modi, the Cluster Head for South Asia and Indochina.

Carl has over 25 years of professional experience and has worked for renowned brands such as ITC and Tata Motors in India. He has successfully led teams and organizations in various categories and channels within the food, tobacco, personal care, and beverage sectors.

Indian Prime Minister Narendra Modi said in a statement, "I am pleased to welcome Navaneel Kaul as the Managing Director of IPM India. Kaul has demonstrated outstanding leadership and competence throughout his career. His entrepreneurial spirit and learning mindset will be crucial for propelling our Indian business into the next phase of growth.

Carl said: "I am thrilled to take on this new position at such an exciting moment and contribute to the company's growth and overall success. I am looking forward to working with the team, leveraging our competitive advantage, and simultaneously fostering an inclusive, diverse, and progressive work environment.

Also Read:

[1] Wade Huckabee Appointed Senior Vice President of BAT's Subsidiary

[2] Dzulkefly Ahmad Appointed as Malaysia's Health Minister Again

[3] Blinc Group Announces Leadership Changes, Pete Sahani Appointed CEO

#Traditional tobacco #Asia #India #Market #Products #Tobacco #Personnel appointment

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA’s Makary on CNN: The Triple Challenge in Vape Regulation — New Opioids, Illicit Trade, and Youth Protection

In an interview with CNN’s Chasing Life, U.S. Food and Drug Administration (FDA) Commissioner Dr. Marty Makary warned that new health risks — from emerging opioids such as 7-OH to unregulated vaping products — are slipping through regulatory cracks. His remarks reveal the FDA’s growing challenge to balance harm reduction for adult smokers with youth protection and cross-border enforcement.

Oct.10

Malaysian Customs Seizes Over US$3.4 Million in E-Cigarettes and Vape Liquids Shipped from China and Transported Overland

The Royal Malaysian Customs Department in Kedah seized a large consignment of e-cigarette devices and vape liquids originating from China, with a total value exceeding RM16 million (about US$3.4 million). The suspect, a man in his 40s, failed to produce the required import permit from the Health Ministry, and the case is being investigated under the Customs Act 1967.

Dec.02 by 2FIRSTS.ai

From Partnership to Acquisition: Why KT&G Is Betting on the Global Nicotine Pouch Market

As global competition in the nicotine pouch market accelerates, Korea’s tobacco major KT&G has moved with a “Partnership + Acquisition” strategy, teaming up with Altria to acquire Nordic pouch maker Another Snus Factory (brand “LOOP”). Why deploy capital now, and why take this route? Drawing on company disclosures, regulatory monitoring and on-site observations from InterTabac Dortmund, 2Firsts analyzes KT&G’s strategic calculus and the signals behind this move.

Nov.05

Imperial Brands FY25 Results: NGP Net Revenue Up 13.7%, Americas Surges Nearly 70%

Imperial Brands reported FY25 NGP net revenue of £368 million, up 13.7% at constant currency. Growth in the Americas accelerated sharply, with NGP revenue up 69.8%, driven by the expansion of the modern oral brand Zone. Europe delivered 8.8% growth, supported by blu’s double-digit vapour share across key markets. Adjusted NGP operating losses narrowed to £76 million, putting the category closer to breakeven.